The Food and Drug Administration has been investigating the use of the type 2 diabetes medication, Actos, since September 2010. In June 2011, the FDA announced that medications containing the ingredient pioglitazone( an active ingredient in Actos) must have a warning label on them about extended use of the medication and its link to bladder cancer.
Data from a 10-year ongoing study were looked into when it was determined that if a person used Actos for period of 24 months, there was an increased risk of bladder cancer associated with it. The FDA has warned physicians to be more careful when prescribing the medication, especially if the person has a history of bladder cancer in their family.
If you or a loved one has developed bladder cancer as a result of using Actos, you need experienced representation on your side. Contact the Actos lawsuit attorneys of Williams Kherkher in order to discuss your legal options.